These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32571260)
21. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML. Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032 [TBL] [Abstract][Full Text] [Related]
22. HoxA10 protein regulates transcription of gene encoding fibroblast growth factor 2 (FGF2) in myeloid cells. Shah CA; Bei L; Wang H; Platanias LC; Eklund EA J Biol Chem; 2012 May; 287(22):18230-48. PubMed ID: 22493287 [TBL] [Abstract][Full Text] [Related]
23. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia. Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia. Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758 [TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507 [TBL] [Abstract][Full Text] [Related]
26. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia. Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964 [TBL] [Abstract][Full Text] [Related]
27. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia. Ma QL; Wang JH; Yang M; Wang HP; Jin J J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187 [TBL] [Abstract][Full Text] [Related]
28. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Zhao X; Li Y; Wu H Int J Mol Med; 2018 Sep; 42(3):1495-1507. PubMed ID: 29956722 [TBL] [Abstract][Full Text] [Related]
29. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia. Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819 [TBL] [Abstract][Full Text] [Related]
30. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia. Prijić S; Ugrina I; Labar B; Nemet D; Batinić J; Zadro R; Ries S; Gjadrov-Kuvedžić K; Davidović S; Batinić D Leuk Lymphoma; 2015; 56(8):2281-8. PubMed ID: 25426669 [TBL] [Abstract][Full Text] [Related]
33. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia. Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096 [TBL] [Abstract][Full Text] [Related]
34. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients. Shi H; Gao L; Zhang W; Jiang M BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia. Xu X; Sun R; Li Y; Wang J; Zhang M; Xiong X; Xie D; Jin X; Zhao M BMC Med Genomics; 2023 May; 16(1):117. PubMed ID: 37237254 [TBL] [Abstract][Full Text] [Related]
36. Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia. Li G; Gao Y; Li K; Lin A; Jiang Z Oncol Lett; 2020 Aug; 20(2):1824-1834. PubMed ID: 32724426 [TBL] [Abstract][Full Text] [Related]
37. Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML. Abdelhafiz AS; Elsayed GM; Saber MM; Gameel A; Hamdy N Int J Lab Hematol; 2020 Jun; 42(3):263-269. PubMed ID: 32048789 [TBL] [Abstract][Full Text] [Related]
38. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Li Z; Huang H; Li Y; Jiang X; Chen P; Arnovitz S; Radmacher MD; Maharry K; Elkahloun A; Yang X; He C; He M; Zhang Z; Dohner K; Neilly MB; Price C; Lussier YA; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Bullinger L; Valk PJ; Delwel R; Lowenberg B; Liu PP; Marcucci G; Bloomfield CD; Rowley JD; Chen J Blood; 2012 Mar; 119(10):2314-24. PubMed ID: 22251480 [TBL] [Abstract][Full Text] [Related]
39. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia. Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380 [TBL] [Abstract][Full Text] [Related]
40. Screening of prognostic risk microRNAs for acute myeloid leukemia. Gao HY; Wang W; Luo XG; Jiang YF; He X; Xu P; Chen X; Li XY Hematology; 2018 Dec; 23(10):747-755. PubMed ID: 29781401 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]